***Note to Authors: please make sure your contact address information is clearly visible on the outside of all packages you are sending to Editors.***
Aims and Scope
Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published every other month, Ocular Immunology and Inflammation provides an international forum for the publication of basic and clinical research reports on both ocular and intraocular inflammation, as well as the ocular inflammatory response and its control by the immune system.
Ocular Immunology and Inflammation publishes full-length original articles, brief case reports, editorials and Journal Watch. Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical concerns with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.
Manuscript Submission
Ocular Immunology and Inflammation receives all manuscript submissions electronically via our Manuscript Central website located at http://mc.manuscriptcentral.com/noii. Manuscript Central allows for rapid and easy submission of original and revised manuscripts, as well as reviewing and internal communication between authors, editors and reviewers via a web-based platform.
Ocular Immunology and Inflammation uses an online peer view system. Only original papers will be considered. Authors are responsible for obtaining permission to reproduce copyrighted material from other sources and are required to sign an agreement for the transfer of copyright to the publisher. All accepted manuscripts, artwork, and photographs become property of the publisher.
Getting Started
To submit a manuscript, please follow the instructions below:
Launch your web browser (Internet Explorer 5 or higher or Netscape 6 or higher) and go to the Manuscript Central homepage (http://mc.manuscriptcentral.com/noii). Log-in or click the "Create Account" option if you are a first-time user of Manuscript Central.
If you are creating a new account:
After clicking on "Create Account" enter your name and e-mail information and click "Next". Your e-mail information is very important.
Enter your institution and address information as prompted then click "Next."
Enter a user ID and password of your choice (we recommend using your e-mail address as your user ID) and then select your area of expertise. Click "Finish" when done.
Log-in and select "Author Center."
Submitting Your Manuscript
After you have logged in, click the "Submit a Manuscript" link in the menu bar.
Enter data and answer questions as prompted
Click on the "Next" button on each screen to save your work and advance to the next screen.
Your will be prompted to upload your files:
Click on the "Browse" button and locate the file on your computer.
Select the description of the file in the drop down next to the Browse button.
When you have selected all files you wish to upload, click the "Upload" button.
Review your submission (in both PDF and HTML formats) before sending to the Editors. Click the "Submit" button when you are done reviewing.
You may stop a submission at any phase and save it to submit later. Acknowledgment of receipt of the manuscript by the editorial office will be sent to the corresponding author, including an assigned manuscript number that should be included in all subsequent correspondence. Revised manuscripts should be submitted via your Author Center to ensure that they are linked to the original submission. You can also log-on to Manuscript Central any time to check the status of your manuscript. You will receive an e-mail once a decision has been made on your manuscript.
Cover Letter
Manuscripts must be accompanied by a cover letter that should include information on prior or duplicate publication or submission, as well as the originality of the manuscript and other information that the authors want to convey to the Editor-in-Chief. If the manuscript has been previously rejected or evaluated in any form by another journal, the authors should note that in the cover letter and indicate how they have improved the manuscript.
The principal investigator or the Corresponding Author of a manuscript containing original data must confirm in the cover letter that he or she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis as well as the decision to submit for publication. Cover letters for revised manuscripts must answer, point by point, any concerns noted by reviewers.
Preparation of Manuscripts: Original Articles
Manuscripts should be prepared using MS Word and should be clearly labeled with the authors' name. All parts of the manuscript should be double-spaced, with margins of at least one inch on all sides. Note that Scholar One Manuscript Central will automatically assign each page a running head and footer, as well as page numbers and line numbers to your manuscript. Best online viewing results for authors and reviewers will be obtained with original files that DO NOT contain page numbers, line numbers, or any information in the manuscript header or footer.
Authors should supply a shortened version of the title suitable for the running head, not exceeding 50 character spaces. Each article should be summarized in a structured abstract of not more than 150 words. Avoid abbreviations, diagrams, and reference to the text in the abstract. To expedite the review process, authors may recommend up to 4 reviewers. Please provide the complete name, university affiliation and email address for each reviewer. Note that recommended reviewers will be used at the discretion of the editor.
Structure of Original Articles
Structured Abstracts
Ocular Immunology and Inflammation publishes abstracts using the structured format. The abstract therefore must be divided into sections with the following headings:
PURPOSE
METHODS
RESULTS
CONCLUSIONS
Keywords
Up to five key words, which may or may not appear in the title, should be given in alphabetical order, on the title page, each separated by a semicolon (;). In addition to being printed in the article, these key words form the sole basis of the annual Subject Index.
Text
The text should be divided into the following sections:
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
REFERENCES
Acknowledgements
These should appear on a separate sheet at the end of the written section, before the references.
Declaration of interest It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict)
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.
All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.
If no conflict is declared, the following statement will be attached to all articles:
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.
References
References should be numbered consecutively in the text and in the reference list. In the text, reference numbers are entered as superscripts. The references must be verified by the author(s) against the original documents. PubMed offers a useful reference checker at http://www.ncbi.nlm.nih.gov/entrez/query/static/citmatch.html
References to journal articles should follow the AMA format and include:
1) the author or authors (list 3; for more than three authors, list the first three followed by "et al.")
2) title
3) journal name (as abbreviated in MEDLINE)
4) year
5) volume number
6) inclusive page numbers
References to books should include:
1) the author or authors
2) chapter title (if any)
3) editor or editors (if any)
4) book title
5) edition (other than the first)
6) city of publication
7) publisher
8) copyright year
9) inclusive pages of the chapter or section cited
Examples:
Journal: Vega KJ, Pina J, Krevsky B, et al. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med. 1996:124(2):2980-983.
Book: Millman, M. (1980). Such a pretty face. New York: W. W. Norton.
Contribution to a Book: Hartley, J. T., & Walsh, D. A. (1980). Contemporary issues in adult development of learning. In L. W. Poon (ed.), Ageing in the 1980s (pp. 239-252). Washington, DC: American Psychological Association.
A reference to a study that has been accepted for publication but is not yet published or reference to an Epub article should be identified as "in press." The reference should name the journal or other publication in which the study will appear. Association for Research in Vision and Ophthalmology (ARVO) and other abstract references are discouraged.
Illustrations
Illustrations submitted (line drawings, halftones) should be digital files. They should follow these guidelines:
- 300 dpi or higher (no higher than 600 dpi)
- Sized to fit on journal page
- EPS, TIFF, or PSD format only
- Submitted as separate files, not embedded in text files
Color illustrations will be considered for publication; however, the author will be required to bear the full cost involved in their printing and publication. The charge for the first page with color is $1000.00. The next three pages with color are $500.00 each. A custom quote will be provided for color art totaling more than 4 journal pages. The publisher has the right to refuse publication of color prints deemed unacceptable.
Tables and Figures
Tables and figures should not be embedded in the text but instead included as separate files. A short descriptive title should appear above each table with a clear legend, and any footnotes suitably identified below. All units must be included.
Figures should be completely labeled, taking into account necessary size reduction. Each caption should be numbered consecutively in the text, have a brief title, and contain a complete description of each figure. The title and caption should contain enough information so that the figure can be understood independent of the manuscript text. Use complete sentences for the captions except in the title.
Figures submitted should be digital files. When submitting figures with your manuscript please include figure files that are no bigger than 600 dpi and a 50 MB file size.
Proofs
Proofs will be sent to the corresponding Author. Proofs should be carefully checked and returned within 48 hours.
Complimentary Policy
Each corresponding author will receive one PDF of their article. Reprints of individual articles are available for order at the time authors review page proofs. A discount on reprints is available to authors who order before print publication.
Preparation of Manuscripts: Case Reports
A Case Report is original content with either a single case or a small case series. Case Reports should adhere to the requirements of Original Articles except as specifically noted hereafter.
Abstracts
Include a structured abstract of 100 words or less with the following headings:
PURPOSE
DESIGN
METHODS
RESULTS
CONCLUSIONS
Text
The text is limited to 500 words.
References
Case Reports are limited to five references. Please refer to the References section of Original Articles for the format to be used.
Offline Manuscript Submission
Since all manuscripts are reviewed and processed online, all authors are requested to submit their manuscripts through the Manuscript Central system. However, if technical restrictions mean a submission cannot be completed online, please e-mail small files to the office at hank.kaplan@louisville.edu or send larger files on a CD-ROM disk containing properly formatted digital files of the manuscript and figures. Other queries may be sent to:
Manfred Zierhut, Editor-in-Chief
Ocular Immunology & Inflammation
Department of Ophthalmology
University of Tuebingen
Schleischstr 12
If the Ocular Immunology and Inflammation office uploads a manuscript on behalf of an author, the Corresponding Author will receive an e-mail receipt of the manuscript and related notices regarding the manuscript. Once a manuscript has been uploaded into the system, the Corresponding Author should log in to the system to follow the progress of the manuscript.
Manuscript Review and Selection
Full-Length Articles, Editorials, and Case Reports are peer-reviewed. After an initial review of the manuscript, the Editor-in- Chief selects a Reviewing Editor who is an expert in the field and who will be responsible for guiding the manuscript through the review process. The Reviewing Editor then selects several outside reviewers to ensure that at least two reviews are completed. Ocular Immunology and Inflammation does not reveal the identity of its reviewers.
Once these reviews are completed, the Reviewing Editor critiques and synthesizes the comments of the reviewers, and provides additional comments to the Editor-in-Chief. The Editor-in-Chief reviews the manuscript together with all comments and makes the publication decision, which is then e-mailed to the Corresponding Author, along with consolidated comments of the reviewers of the manuscript.
Recommend
Mark
Alert
Link
Print
